Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Dialysis EVAR Embolization HTN Limb Salvage Neurointervention Oncology PE Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

Search Results

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

Sponsored by Cagent Vascular

evt | Article | September 2026 Supplement

Achieving Durable Results Above the Knee

A consistent algorithm for complex femoropopliteal disease.

By Michael L. Campbell, MD

evt | Article | November 2005

Uterine Artery Embolization of Uterine Fibroids

By Michael L. Censullo, MD; Polina N. Kyriakides, MD; Lucho L. Rossman, MD; and Alan M. Cohen, MD

evt | Article | February 2005

Subclavian and Vertebral Occlusive Disease

An overview of the clinical syndromes and therapeutic strategies.

By Mark H. Wholey, MD, and Michael H. Wholey, MBA, MD

evt | Article | January 2020

The Current State of Stroke Therapy: Endovascular Surgery for the Treatment of Intracranial and Extracranial Vascular Disease

A review of past and future topics in ischemic stroke care.

By Gary B. Rajah, MD; Michael K. Tso, MD, PhD; Rimal H. Dossani, MD; and Adnan H. Siddiqui, MD, PhD

Advertisement

Sponsored by Inari Medical

evt | Article | March 2022

Long-Term Consequences of DVT: Is Mechanical Thrombectomy the Answer?

Despite challenging patient presentations, the ClotTriever System shows great promise in patients with recurrent deep vein thrombosis, chronic thrombus, and venous ulcers.

With Dustin Harmon, DO, FACC; Michael Larone Campbell, MD; and Angelo G. Marino, DO

evt | News | February 10, 2015

ESCAPE and EXTEND-IA Trials Confirm Benefits of Medtronic's Solitaire Flow Restoration Device for Stroke

February 11, 2015—Medtronic, plc announced that two studies presented at the International Stroke Conference in Nashville, Tennessee, and published online in The New England Journal of Medicine found that stent thrombectomy using the company’s Solitaire device added to the current standard of pharmaceutical treatment with intravenous tissue plasminogen activator (IV-tPA) significantly reduced disability in patients experiencing a stroke.  Both the ESCAPE (Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke) and the EXTEND-IA (Extending the Time for Thrombolysis in Emergency Neurological Deficits—Intra-Arterial) trials were investigator-initiated trials supported by an unrestricted grant from Medtronic that primarily assessed the addition of the company’s Solitaire device in conjunction with IV-tPA.

evt | Article | September 2009

PTA and Stenting of Extracranial VAS

Percutaneous angioplasty and stent placement should be the first treatment proposed for VBI caused by vertebral artery stenosis.

By Michel Henry, MD; Antonios Polydorou, MD; Isabelle Henry, MD; and Michèle Hugel, RN

evt | Article | July 2024

Recapping Influential Superficial Venous Trials

A summary of formative published literature with a significant impact to the advancement of superficial venous care.

By Manj S. Gohel, MD, FRCS, FEBVS

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button